| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999502 | Urologic Oncology: Seminars and Original Investigations | 2015 | 7 Pages |
Abstract
Although a new diagnosis of a smoking-related GU malignancy diagnosis offers greater opportunity for provider-driven smoking cessation, timely multimodal claims-based cessation interventions are underreported or underused.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Liam C. M.D., M.P.H., Jessica C. M.D., Sarah K. Ph.D., Jeffrey C. M.D., Jonathan L. M.D., M.S., John L. M.D., M.S.,